JPH1192353A - Skin preparation for external use for inhibiting sebum synthesis - Google Patents

Skin preparation for external use for inhibiting sebum synthesis

Info

Publication number
JPH1192353A
JPH1192353A JP9255029A JP25502997A JPH1192353A JP H1192353 A JPH1192353 A JP H1192353A JP 9255029 A JP9255029 A JP 9255029A JP 25502997 A JP25502997 A JP 25502997A JP H1192353 A JPH1192353 A JP H1192353A
Authority
JP
Japan
Prior art keywords
sebum
skin
external use
extract
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP9255029A
Other languages
Japanese (ja)
Other versions
JP3819126B2 (en
Inventor
Atsushi Ouchi
敦 大内
Mitsuyuki Hotta
光行 堀田
Satoshi Kanazawa
聡 金澤
Yoshinori Nishizawa
義則 西澤
Kimihiko Hori
公彦 堀
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP25502997A priority Critical patent/JP3819126B2/en
Publication of JPH1192353A publication Critical patent/JPH1192353A/en
Application granted granted Critical
Publication of JP3819126B2 publication Critical patent/JP3819126B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To prepare the subject preparation for external use, capable of continuously inhibiting the secretion of sebum on skin or scalp, hardly causing side effects and high in safety by formulating an extract of Echinacea angustifolia and E.purpurea, and/or Tropaeolum majus as an active ingredient. SOLUTION: The objective preparation for external use is obtained by formulating 0.01-10 wt.%, preferably 0.5-5 wt.% extract obtained by carrying out an extraction treatment of pulverized material of root or whole plant of Echinacea angustifolia and E.purpurea, and/or leaf of Tropaeolum majus with one or mixture of two or more kinds of ethanol, propylene glycol, 1,3-butylene glycol and water at 3-70 deg.C, in terms of the dried weight based on the amount of the preparation for the external use as an active ingredient.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、エキナケア等の生
薬の抽出エキスを有効成分とする皮脂合成抑制用皮膚外
用剤に関する。
TECHNICAL FIELD The present invention relates to a skin external preparation for suppressing sebum synthesis, comprising an extract of a crude drug such as echinacea as an active ingredient.

【0002】[0002]

【従来の技術】皮膚や頭皮の皮脂腺より分泌される皮脂
は、皮膚を柔軟かつ滑らかに保ち、毛髪に対しては必要
かつ適度の油分として供給されることにより、毛髪のし
なやかさや美しさを保つ上で有効な成分であり、皮膚や
毛髪にとって必要とされるものである。また皮脂は外界
からの様々な刺激物が皮膚または頭皮表面から侵入する
ことを防ぐ一方、皮膚または頭皮角層からの水分の損失
を防ぐ上で重要な役割を果たしている。
2. Description of the Related Art Sebum secreted from the sebaceous glands of the skin and scalp keeps the skin soft and smooth, and keeps the hair supple and beautiful by being supplied to the hair as a necessary and appropriate oil component. It is an active ingredient above and is required for skin and hair. Sebum also plays an important role in preventing various irritants from the outside from invading the skin or the scalp surface, while preventing water loss from the skin or the stratum corneum.

【0003】しかしながら、皮脂腺の活動が過度に亢進
し皮脂の分泌が多くなりすぎると、かえってざ瘡、脂漏
性皮膚疾患等の皮膚炎、さらには種々の皮膚トラブルの
原因となり、頭皮においてはフケの増加、脱毛等の原因
となる。また過剰の皮脂は皮膚及び頭皮での美容上好ま
しくない状態(肌や髪のベタツキ)、微生物や病原菌の
増殖を促進し、様々な皮膚異常を引き起こす要因とな
る。
However, if the activity of sebaceous glands is excessively increased and secretion of sebum becomes excessive, dermatitis such as acne and seborrheic dermatosis and various skin troubles are caused, and dandruff is caused on the scalp. Causes increase in hair loss and hair loss. In addition, excessive sebum promotes the growth of microorganisms and pathogenic bacteria, which are undesirable in a cosmetically unsatisfactory state (skin and hair stickiness) on the skin and scalp, and causes various skin abnormalities.

【0004】このような皮脂の過剰分泌に起因する皮膚
炎、皮膚トラブル、美容、化粧上の問題を解決あるいは
予防する目的で、従来より石鹸等で洗浄することによ
り、皮脂を除去することが行われている。
[0004] For the purpose of solving or preventing dermatitis, skin trouble, beauty and cosmetic problems caused by such excessive secretion of sebum, it has conventionally been practiced to remove sebum by washing with soap or the like. Have been done.

【0005】[0005]

【発明が解決しようとする課題】しかしながら、石鹸等
を用いた過剰皮脂の除去効果は一時的なものであり、皮
脂の過剰分泌を抑えて、根本的に皮脂の分泌過剰に起因
する皮膚炎、皮膚トラブルを改善することができないと
いう問題がある。
However, the effect of removing excess sebum using soap or the like is temporary, and it suppresses excessive secretion of sebum, and dermatitis caused by excessive secretion of sebum fundamentally. There is a problem that skin troubles cannot be improved.

【0006】したがって本発明は、皮膚や頭皮における
皮脂の分泌を持続的に抑制し、副作用がなく安全性が高
い、皮脂合成抑制用皮膚外用剤を提供することを目的と
する。
Accordingly, an object of the present invention is to provide a skin external preparation for suppressing sebum synthesis, which suppresses sebum secretion in the skin and scalp continuously, has no side effects and is highly safe.

【0007】[0007]

【課題を解決するための手段】本発明者らは上記目的を
達成すべく鋭意研究した結果、潰瘍や外傷感染症の治療
薬として従来から用いられ、副作用のない生薬として知
られているエキナケア及び/またはキンレンカの抽出物
が、安全性が高く、かつ皮膚や頭皮における皮脂の分泌
を持続的に抑制し得ることを見出し、本発明を完成させ
た。
Means for Solving the Problems The present inventors have conducted intensive studies to achieve the above object, and as a result, Echinacea, which is conventionally used as a remedy for ulcers and trauma infections and is known as a crude drug without side effects, has been developed. The present inventors have found that an extract of nasturtium has high safety and can continuously suppress sebum secretion in skin and scalp, and completed the present invention.

【0008】すなわち本発明は、エキナケア及び/また
はキンレンカの抽出物を有効成分とする皮脂合成抑制用
皮膚外用剤を提供するものである。
That is, the present invention provides a skin external preparation for suppressing sebum synthesis, comprising an extract of Echinacea and / or Nasturtium as an active ingredient.

【0009】[0009]

【発明の実施の形態】本発明において、エキナケアは、
Echinacea angustifoliaまたは
E.purpurea(ムラサキバレンギク)の根また
は全草である。主成分はエキナコシド(Echinac
osid)という弱い抗生作用のある配糖体であり、そ
の他精油、イヌリン、ベタイン、樹脂等を含有してい
る。エキナケアは、各種の症状に対して全身性の特異的
抵抗力増大を目的とする植物性薬剤の典型として用いら
れており、一般的な用量では副作用は全くない。また経
口投与、静脈内注射、筋肉内注射、外用のいずれも可能
である。
DETAILED DESCRIPTION OF THE INVENTION In the present invention, echinacea is
Echinacea angustifolia or E. coli. It is the root or whole plant of purpurea. The main component is echinacoside (Echinac
osid), which is a glycoside having a weak antibiotic action and contains essential oils, inulin, betaine, resins and the like. Echinacea is used as a typical botanical drug aimed at increasing systemic specific resistance to various symptoms, and has no side effects at ordinary doses. In addition, oral administration, intravenous injection, intramuscular injection, and external use are all possible.

【0010】キンレンカは、Tropaeolum m
ajusの葉である。キンレンカは弱いが全く無害の抗
生作用を有する物質を含有しており、耐性やアレルギー
を引き起こすことがない。従来より外傷感染症治療薬と
して用いられている。
Nasturtium is Tropaeolum.
ajus leaves. Nasturtium contains a substance that has a weak but harmless antibiotic action and does not cause resistance or allergy. It has been used as a therapeutic agent for wound infections.

【0011】本発明に用いられるエキナケア、キンレン
カの抽出物は、例えば以下の方法により得ることができ
る。すなわち上記植物の粉砕物を通常3〜100℃で水
及び/または石油エーテル、n−ヘキサン、シクロヘキ
サン、四塩化炭素、トルエン、ベンゼン、ジクロロメタ
ン、クロロホルム、エーテル、酢酸エチル、ブタノー
ル、アセトン、プロパノール、エタノール、メタノー
ル、プロピレングリコール、1,3−ブチレングリコー
ル等の1種または2種以上の混合物、好ましくはエタノ
ール、プロピレングリコール、1,3−ブチレングリコ
ール、及び水の1種または2種以上の混合物を用い、通
常3〜70℃で抽出処理して得ることができる。かかる
抽出物をさらに適当な分離手段、例えばゲル濾過やシリ
カゲルカラムクロマト法、高速液体クロマト法等によ
り、より活性の高い画分を分画して用いることもでき
る。
The extracts of Echinacea and Nasturtium used in the present invention can be obtained, for example, by the following method. That is, the pulverized product of the above plant is usually subjected to water and / or petroleum ether, n-hexane, cyclohexane, carbon tetrachloride, toluene, benzene, dichloromethane, chloroform, ether, ethyl acetate, butanol, acetone, propanol, ethanol at 3 to 100 ° C. , Methanol, propylene glycol, a mixture of one or more of 1,3-butylene glycol and the like, preferably, a mixture of one or more of ethanol, propylene glycol, 1,3-butylene glycol, and water. , Usually at 3 to 70 ° C. Such an extract can be further fractionated and used for a more active fraction by a suitable separation means, for example, gel filtration, silica gel column chromatography, high performance liquid chromatography, or the like.

【0012】かかるエキナケア、キンレンカ抽出物は、
使用時の感触、効果等の点から皮脂合成抑制用皮膚外用
剤中、乾燥重量で0.01〜10重量%配合することが
好ましく、0.5〜5重量%配合することが特に好まし
い。
The echinacea and nasturtium extract are as follows:
From the viewpoints of feel and effect at the time of use, it is preferable to mix 0.01 to 10% by weight, particularly preferably 0.5 to 5% by weight, in a dry weight of the skin external preparation for suppressing sebum synthesis.

【0013】本発明においては、本発明の効果を害さな
い範囲で、界面活性剤、油分、保湿剤、収斂剤、清涼
剤、酸化防止剤、アルコール類、キレート類、pH調整
剤、防腐剤、増粘剤、色素、香料、抗炎症剤、角解剤、
抗菌剤、殺菌剤等の薬効成分の他、医薬品、化粧品、医
薬部外品等に一般に用いられる公知成分を適宜配合する
ことができる。
In the present invention, a surfactant, an oil, a humectant, an astringent, a cooling agent, an antioxidant, an alcohol, a chelate, a pH adjuster, a preservative, and the like, as long as the effects of the present invention are not impaired. Thickeners, pigments, fragrances, anti-inflammatory agents, deflocculants,
Known components generally used in pharmaceuticals, cosmetics, quasi-drugs, and the like, as well as medicinal components such as antibacterial agents and bactericides, can be appropriately compounded.

【0014】本発明の皮脂合成抑制用皮膚外用剤の剤型
に特に制限はないが、例えば液状、軟膏、ゲル、エアゾ
ール等任意のものとすることができ、具体的にはW/O
乳化型皮膚外用剤、O/W乳化型皮膚外用剤、クリー
ム、化粧乳液、化粧水、油性化粧水、パック、ファンデ
ーション等が挙げられる。
The dosage form of the skin external preparation for inhibiting sebum synthesis according to the present invention is not particularly limited. For example, it can be in any form such as liquid, ointment, gel, aerosol and the like.
Emulsified skin external preparations, O / W emulsified skin external preparations, creams, cosmetic emulsions, lotions, oily lotions, packs, foundations and the like can be mentioned.

【0015】本発明の皮脂合成抑制用皮膚外用剤は、前
記必須成分及び必要に応じて任意成分を、常法に従い、
混合、撹拌等することにより得ることができる。
The skin external preparation for inhibiting sebum synthesis according to the present invention comprises the above essential components and optional components as necessary, according to a conventional method.
It can be obtained by mixing and stirring.

【0016】[0016]

【実施例】次に実施例を示して本発明をさらに詳細に説
明するが、本発明は以下の実施例に限定されるものでは
ない。
EXAMPLES Next, the present invention will be described in more detail with reference to examples, but the present invention is not limited to the following examples.

【0017】実施例1 エキナケア抽出物を有効成分とする皮脂合成抑制用皮膚
外用剤の製造:乾燥エキナケアの細断物10gを、50
%プロピレングリコール水溶液で抽出し、エキス固形分
濃度が1.1%(v/w)のエキナケア抽出物100g
を製造し、その一部を70%エタノールに5%濃度にな
るように希釈し、皮脂合成抑制用皮膚外用剤50gを製
造した。
Example 1 Preparation of a skin external preparation for suppressing sebum synthesis containing an echinacea extract as an active ingredient:
100 g of echinacea extract having an extract solids concentration of 1.1% (v / w)
Was partially diluted with 70% ethanol to a concentration of 5% to prepare 50 g of a skin external preparation for suppressing sebum synthesis.

【0018】実施例2 キンレンカ抽出物を有効成分とする皮脂合成抑制用皮膚
外用剤の製造:乾燥キンレンカの細断物15gを、50
%プロピレングリコール水溶液で抽出し、エキス固形分
濃度が1.3%(v/w)のキンレンカ抽出物130g
を製造し、その一部を70%エタノールに5%濃度にな
るように希釈し、皮脂合成抑制用皮膚外用剤50gを製
造した。
Example 2 Preparation of a skin external preparation for inhibiting sebum synthesis using a nasturtium extract as an active ingredient:
% Propylene glycol aqueous solution, extract solid concentration is 1.3% (v / w), 130 g of nasturtium extract
Was partially diluted with 70% ethanol to a concentration of 5% to prepare 50 g of a skin external preparation for suppressing sebum synthesis.

【0019】試験例1 皮脂合成抑制能試験:生後10週齢の雄ハムスターの右
耳介部に、実施例1、実施例2で得られた皮脂合成抑制
用皮膚外用剤を、1日1回20μlずつ2週間連続塗布
した。また対照として、左耳介部に70%エタノール
(対照品)を、右耳介部の場合と同様に塗布した。塗布
終了後(塗布開始2週間後)左右耳介部の皮膚組織片
(径4mm)を器官培養し、14C−酢酸をトレーサー
として皮脂合成能(右耳介部の皮脂合成能×100/左
耳介部の皮脂合成能(%))を求めた。
Test Example 1 Test for Sebum Synthesis Inhibition: The skin external preparation for sebum synthesis suppression obtained in Examples 1 and 2 was applied to the right auricle of a 10-week-old male hamster once a day. 20 μl was applied continuously for 2 weeks. As a control, 70% ethanol (control product) was applied to the left pinna in the same manner as in the right pinna. After completion of the application (two weeks after the start of application), the skin tissue pieces (diameter 4 mm) of the left and right auricles were organ-cultured, and the sebum synthesizing ability (sebum synthesizing ability of the right auricle x 100 / left ear) using 14C-acetic acid as a tracer The sebum synthesizing ability (%) of the middle part was determined.

【0020】その結果、実施例1の皮脂合成抑制用皮膚
外用剤(エキナケアエキス含有)を用いた場合は68.
5%であり、また実施例2の皮脂合成抑制用皮膚外用剤
(キンレンカエキス含有)を用いた場合は76.3%で
あり、顕著な皮脂合成抑制効果が認められた。特に実施
例1の皮脂合成抑制用皮膚外用剤を用いた場合は、危険
率5%でt検定による有意差があり、より顕著な効果が
認められた。
As a result, when the skin external preparation for suppressing sebum synthesis (containing echinacea extract) of Example 1 was used, the amount was 68.
5%, and 76.3% when the skin external preparation for sebum synthesis suppression (containing nasturtium extract) of Example 2 was used, and a remarkable sebum synthesis suppression effect was recognized. In particular, when the skin external preparation for suppressing sebum synthesis of Example 1 was used, there was a significant difference by a t-test at a risk factor of 5%, and a more remarkable effect was recognized.

【0021】[0021]

【発明の効果】本発明の皮脂合成抑制用皮膚外用剤は、
皮膚や頭皮における皮脂の分泌を持続的に抑制するとと
もに、副作用がなく安全性が高いものである。
The skin external preparation for inhibiting sebum synthesis according to the present invention comprises:
It is highly safe as it suppresses sebum secretion in the skin and scalp continuously and has no side effects.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 西澤 義則 栃木県芳賀郡市貝町赤羽2606 花王株式会 社研究所内 (72)発明者 堀 公彦 栃木県芳賀郡市貝町赤羽2606 花王株式会 社研究所内 ──────────────────────────────────────────────────続 き Continuing on the front page (72) Inventor Yoshinori Nishizawa 2606 Kabane-cho, Akaga-cho, Haga-gun, Tochigi Pref. Within the Kao Co., Ltd. (72) Inventor Kimihiko Hori 2606, Akabane-Akabane, Kaiga-cho, Haga-gun, Tochigi pref.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 エキナケア(Echinacea angustifolia及
びE.purpurea)及び/またはキンレンカ(Tropaeolum m
ajus)の抽出物を有効成分とする皮脂合成抑制用皮膚外
用剤。
Claims 1. An echinacea (Echinacea angustifolia and E. purpurea) and / or nasturtium (Tropaeolum m)
A skin external preparation for inhibiting sebum synthesis, comprising an extract of ajus) as an active ingredient.
JP25502997A 1997-09-19 1997-09-19 Skin preparation for inhibiting sebum synthesis Expired - Fee Related JP3819126B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP25502997A JP3819126B2 (en) 1997-09-19 1997-09-19 Skin preparation for inhibiting sebum synthesis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25502997A JP3819126B2 (en) 1997-09-19 1997-09-19 Skin preparation for inhibiting sebum synthesis

Publications (2)

Publication Number Publication Date
JPH1192353A true JPH1192353A (en) 1999-04-06
JP3819126B2 JP3819126B2 (en) 2006-09-06

Family

ID=17273197

Family Applications (1)

Application Number Title Priority Date Filing Date
JP25502997A Expired - Fee Related JP3819126B2 (en) 1997-09-19 1997-09-19 Skin preparation for inhibiting sebum synthesis

Country Status (1)

Country Link
JP (1) JP3819126B2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2806623A1 (en) * 2000-03-23 2001-09-28 Silab Sa Active principle extracted from nasturtium used in cosmetic formulations for the depigmenting and lightening of the skin
JP2002012546A (en) * 2000-06-29 2002-01-15 Noevir Co Ltd Skin care preparation
US20110311661A1 (en) * 2003-11-18 2011-12-22 Stephen Behr Plant Extracts and Dermatological Uses Thereof
CN102688151A (en) * 2012-06-05 2012-09-26 东南大学 Tanshinone microemulsion and preparation method thereof
US9022706B2 (en) 2011-12-13 2015-05-05 Stryker Corporation Energy absorbing fastening system

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2806623A1 (en) * 2000-03-23 2001-09-28 Silab Sa Active principle extracted from nasturtium used in cosmetic formulations for the depigmenting and lightening of the skin
JP2002012546A (en) * 2000-06-29 2002-01-15 Noevir Co Ltd Skin care preparation
US20110311661A1 (en) * 2003-11-18 2011-12-22 Stephen Behr Plant Extracts and Dermatological Uses Thereof
US9022706B2 (en) 2011-12-13 2015-05-05 Stryker Corporation Energy absorbing fastening system
CN102688151A (en) * 2012-06-05 2012-09-26 东南大学 Tanshinone microemulsion and preparation method thereof

Also Published As

Publication number Publication date
JP3819126B2 (en) 2006-09-06

Similar Documents

Publication Publication Date Title
JPH08505630A (en) Pharmaceutical and skin cosmetic compositions containing equine colostrum
JPH08133952A (en) Skin preparation for external use
JP3091045B2 (en) Skin cosmetics
JPH0134965B2 (en)
JPH10114648A (en) Composition for external use for skin
JPH1192353A (en) Skin preparation for external use for inhibiting sebum synthesis
JPS63115807A (en) Cosmetic
JPH11100324A (en) Composition for treating pimple
JP3052104B2 (en) Skin cosmetics
JPH11269043A (en) Cosmetic for scalp and hair
JPH11269042A (en) Cosmetic for scalp and hair
JPH10330243A (en) Skin-whitening cosmetic
JPH08133950A (en) Skin preparation for external use
JPH11302133A (en) Cosmetic for scalp and hair
JP2001199873A (en) Composition for external use
KR100202058B1 (en) Mixed whitening compositions
KR101322850B1 (en) The cosmetic composition for pore-minimizing and inhibition of Sebum Secretion containing the extract of leaves of Mentha arvensis var. piperascens, wheat bud, and Platycodon grandiflorum
JPH08133948A (en) Skin preparation for external use
JP2826142B2 (en) Dandruff inhibitor composition
WO1983000628A1 (en) A method of treating acne vulgaris and composition containing carbamide peroxide
JPH0873340A (en) Skin external preparation
JPH1192339A (en) Hair-restoring and growing material
JPH10273424A (en) Cosmetic for hair
JPH11255621A (en) Cosmetic for scalp and hair
JPS62148427A (en) Skin external preparation

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040809

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20040809

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20050921

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060110

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060313

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20060613

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20060614

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100623

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100623

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110623

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110623

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120623

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120623

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130623

Year of fee payment: 7

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees